The price of Vyvanse (lisdexamfetamine dimesylate) is influenced by several factors, including insurance coverage, pharmacy, and geographic location [1]. As of early 2024, a 30-day supply of Vyvanse could range from approximately $300 to over $700 without insurance, depending on the dosage [2]. With insurance, out-of-pocket costs can be significantly lower, often between $10 and $60 for a 30-day supply, but this varies greatly by plan [1][2].
How much does Vyvanse cost with insurance?
Costs with insurance vary widely based on the specific insurance plan's formulary, copay structure, and deductible [1][2]. Some insurance plans may classify Vyvanse as a preferred brand, leading to lower copays, while others may not cover it as extensively [1]. Patients often find their out-of-pocket expenses for a 30-day supply can be as low as $10 to $60, though this is not universally guaranteed [1][2].
Can you get Vyvanse cheaper without insurance?
Without insurance, the retail price of Vyvanse can be substantial. However, savings are possible through manufacturer coupons, patient assistance programs, or by seeking lower prices at different pharmacies [1][2]. For example, some manufacturer savings cards offer discounts that can reduce the cost, but these often have limitations and are not permanent solutions [2]. Comparing prices across various pharmacies can also yield savings [1].
What are the generic options for Vyvanse?
The patent protection for Vyvanse has expired, paving the way for generic versions [3]. Generic lisdexamfetamine dimesylate capsules became available in the United States in late 2023 [3]. The introduction of generics typically leads to a significant reduction in the overall cost of the medication for consumers [4]. This availability is crucial for improving access to treatment for conditions like ADHD [4].
When did the Vyvanse patent expire?
The primary U.S. patent for Vyvanse was set to expire in August 2023. This expiration allowed for the U.S. Food and Drug Administration (FDA) to approve generic versions of the drug, which began entering the market shortly thereafter [3]. Information on patent expiry dates for specific medications can be found on resources like DrugPatentWatch.com [5].
How do generic Vyvanse prices compare to the brand name?
Once generic versions are available, their prices are generally expected to be substantially lower than the brand-name Vyvanse. This price difference is a common outcome following patent expiration and the market entry of generic competitors [4]. While exact pricing will vary, generics typically offer a more affordable alternative to brand-name drugs.
Are there patient assistance programs for Vyvanse?
Yes, Takeda, the manufacturer of Vyvanse, has offered patient assistance programs and savings cards to help eligible individuals reduce their out-of-pocket costs for the medication [2]. These programs are typically designed for those who are uninsured or underinsured and meet specific income criteria [2]. Details and eligibility requirements can usually be found on the manufacturer's website or through healthcare providers.
What is the mechanism of action for Vyvanse?
Vyvanse is a prodrug that is converted in the body to dextroamphetamine [6]. Dextroamphetamine is a central nervous system stimulant that works by increasing the levels of certain neurotransmitters, primarily dopamine and norepinephrine, in the brain [6]. These neurotransmitters play a role in regulating attention, impulse control, and behavior, which is why stimulants like Vyvanse are effective in treating ADHD [6].
What are the main uses of Vyvanse?
Vyvanse is prescribed to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adults [6]. It is also used to treat moderate to severe binge eating disorder (BED) in adults [6]. Its efficacy stems from its ability to improve focus, reduce impulsivity, and control hyperactive behaviors associated with ADHD, and to reduce the frequency of binge eating episodes in BED [6].
What are the risks or side effects associated with Vyvanse?
Like all medications, Vyvanse carries potential risks and side effects. Common side effects can include decreased appetite, dry mouth, insomnia, weight loss, and anxiety [7]. More serious, though less common, risks include cardiovascular problems such as increased blood pressure and heart rate, as well as psychiatric issues like new or worsening behavior and thought problems, and mania [7]. It is also a substance with a potential for abuse and dependence [7].
Sources:
1. GoodRx, "Vyvanse Prices, Coupons, and Patient Assistance Programs," https://www.goodrx.com/vyvanse
2. Vyvanse Savings Card Information, accessed February 2024.
3. FDA, "FDA Approves First Generic Versions of Vyvanse," https://www.fda.gov/news-events/press-announcements/fda-approves-first-generic-versions-vyvanse
4. U.S. Pharmacopeia, "Generic Drugs: Frequently Asked Questions," https://www.usp.org/resource/generic-drugs-frequently-asked-questions
5. DrugPatentWatch.com, https://drugpatentwatch.com/
6. National Institute of Mental Health, "Attention-Deficit/Hyperactivity Disorder (ADHD) in Children," https://www.nimh.nih.gov/health/topics/attention-deficit-hyperactivity-disorder-adhd
7. Mayo Clinic, "Vyvanse (lisdexamfetamine dimesylate) side effects," https://www.mayoclinic.org/drugs-supplements/vyvanse-oral-capsule-oral-tablet/side-effects/drg-20067179